FDA Approved: SANCUSO — Original Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved SANCUSO (granisetron) under an original NDA by Cumberland Pharmaceuticals Inc. for the prevention of chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• SANCUSO (GRANISETRON)

Snippet

ORIG AP for SANCUSO (GRANISETRON)